Home Industries Market Insights About Us Publisher Contact us

Medical Sterilization Biological Indicator Market Growth, Trends and Forecast to 2028 – Global Analysis End User (Hospitals, Pharma Companies) and By Geography

Categories: Life Science   |   Formate :

MARKET DEFINITION

Biological indicators (BIs), according to ANSI/AAMI and ISO, are test items containing live microorganisms that demonstrate a specific level of resistance to a particular sterilization process. A biological indicator provides information on whether the conditions were met for a particular sterilization method to kill a specific number of germs, providing some level of confidence in the process. Bacterial spores or endospores are the microbes that are most usually used in BIs.They are regarded as some of the hardest to kill. The selection of bacterial spores for a particular sterilizing procedure is also based on the spores' known resistance to that procedure. For instance, Geobacillus stearothermophilus spores exhibit strong resistance to steam and vaporized hydrogen peroxide and are utilized in biological indicators that track these sterilizing processes.

MARKET DYNAMICS  

The primary drivers driving the development of the biological indicators market are the rising adoption of universal sterilization indicators, rising advanced product development, rising commercialization of parenteral therapeutics, diagnosing disease, and development of In-house sterilization monitoring solutions. Additionally, the pandemic's high COVID-19 case count generated an unmet need for research-based biological, indicators. The numerous participants in this industry were given tremendous expansion chances as a result. The Pharmaceutical sector has a big opportunity in the research and development of drugs with the help of the Medical Sterilization Biological Indicator Market.

REPORT SCOPE

The report titled “Global Medical Sterilization Biological Indicator Market – Size, Share, Growth, Opportunities, and Competitive Analysis, 2022 – 2028” offers strategic visions into the global Medical Sterilization Biological Indicator market along with the market size (Value in “US$ Mn”) for the historical period 2017 to 2021 and estimates for the forecast period 2022 to 2028. The RI report is an in-depth study of the global Medical Sterilization Biological Indicator market with a strong focus on key market trends, vital player strategies, and market forecasts. The study also covers key market dynamics, including drivers, restraints, opportunities, challenges, and existing and upcoming pathways that help CXOs make critical business decisions effectively. The global Medical Sterilization Biological Indicator Market is predicted to grow at a significant CAGR over the forecast period from 2022 to 2028.

GEOGRAPHICAL OVERVIEW  

The research report includes a detailed overview of the industry comprising quantitative and qualitative information. It gives a broad overview of the worldwide market forecasts for major segments. It also includes market size and forecast projections for five key regions: North America, Europe, Asia-Pacific (APAC), South America, and the Middle East & Africa (MEA), for the years 2017 to 2028. The market is further divided by categories and countries within each province. The research scrutinizes and forecasts over 20 nations worldwide, as well as the present trend and possibilities in these regions.

MARKET SEGMENTATION  

The Global Medical Sterilization Biological Indicator Market is segmented based on End User, and region. Based on End User, the market has been segmented into Hospitals, Diagnostic Centers, Pharma Companies and Others.

COMPETITION LANDSCAPE  

The RI research report discusses noteworthy developments in the industry as well as organic and inorganic growth strategies being adopted by the Medical Sterilization Biological Indicator market players. The report covers industry activities, including new product launches, mergers & acquisitions, business partnerships, and various expansion initiatives being undertaken by the active players in the market. These developments pave the path for various market participants to strengthen their positioning as well as expand their consumer base. The positive market outlook for the global Medical Sterilization Biological Indicator market is anticipated to present lucrative growth opportunities to the market players. The report also offers detailed profiles of major players in the global Medical Sterilization Biological Indicator market, emphasizing the strategic initiatives, financial information, SWOT analysis, and key development in the Medical Sterilization Biological Indicator industry in the past three years.

Key players in the Global Medical Sterilization Biological Indicator Market have adopted various organic as well as inorganic growth strategies to strengthen their market positioning. Prominent players in the market include:

  • 3M Company
  • Steris Plc.
  • Getinge AB
  • Thermo Fisher Scientific Inc.
  • Mesa Labs, Inc.
  • McKesson Medical-Surgical Inc.
  • Crosstex International, Inc. (Cantel Medical Corp.)
  • Propper Manufacturing Co., Inc.
  • Liofilchem S.r.l.
  • Terragene S.A.
  • GKE-GmbH

COVID-19 IMPACT ANALYSIS ON GLOBAL MEDICAL STERILIZATION BIOLOGICAL INDICATOR MARKET  

The COVID-19 pandemic is still a very personal, individual experience that is also a once-in-a-lifetime worldwide phenomenon with far-reaching consequences. The epidemic has wreaked havoc on people's lives in all nations and communities and also had a negative impact on global economic development in 2020, unlike anything seen in almost a century. The pandemic severely impacted key economies such as India, Brazil, the U.S., France, Russia, the UK, Italy, Turkey, and Argentina. According to estimates, the virus slowed global economic growth by -3.4 percent to -7.6 percent in 2020, with a rebound of 4.2 percent to 5.6 percent expected in 2021. In 2020, global commerce was expected to decline by 5.3 percent, but it is expected to rise by 8.0 percent in 2021.

In contrast to the global economic downturn in the first half of 2020, the economy began to showcase symptoms of a two-track recovery post the second quarter of 2020, with a fledgling rebound in developed nations, however, slower growth in emerging economies. The outbreak of the Covid-19 pandemic has not only resulted in halted production activity but has also disrupted the global supply chain. The research goes on to evaluate the current and future implications of the COVID-19 pandemic both on the target as well as broader market, thereby, providing accurate and trustworthy forecasts.

Report Attribute/Metric

Details

Market Size

In USD Million

CAGR

In % (2022-2028)

Base Year

2021

Forecast Period

2022 – 2028

Historical Data

2017 to 2021

Forecast Unit

Value (US$ Mn)

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors and Trends

Geographies Covered

North America, Europe, Asia-Pacific, South America, and Middle East & Africa

Key Players Analyzed

3M Company, Steris Plc., Getinge AB, Thermo Fisher Scientific Inc., Mesa Labs, Inc., McKesson Medical-Surgical Inc., Crosstex International, Inc. (Cantel Medical Corp.), Propper Manufacturing Co., Inc., Liofilchem S.r.l., Terragene S.A., GKE-GmbH

Customization & Pricing

Available on Request (10% Customization is Free)

RESEARCH PROGRAM DESIGN

KEY QUESTIONS ANSWERED

  1. What is the current size of the global Medical Sterilization Biological Indicator market?
  2. What will be the growth rate of the market over the forecast period?
  3. Who are the key manufacturers/vendors in the Medical Sterilization Biological Indicator market space?
  4. What are the major market opportunities and market risks faced by the market?
  5. What is the impact of COVID-19 on the market?
  6. What are the revenue, sales, and price analysis of the top manufacturers in this market?
  7. What are the key outcomes of Porter's five forces model?
  8. Who are the distributors, traders, and vendors in the industry?

REASONS FOR BUYING THIS REPORT:  

  • The report offers comprehensive data on the Medical Sterilization Biological Indicator market elaborating on the current state and future growth prospects both globally and regionally
  • It offers a six-year market forecast trend evaluating the impact of drivers and restraints and supporting factors for growth
  • The report offers deep-dive insights into each market segment and critical factors responsible for its growth
  • The report presents precise picture of the dynamic competitive landscape which helps our client advance their market position
  • The comprehensive analysis of the market along with the inclusion of analyst recommendations ensures that our clients make informed business decisions
  • Cross-segment country-level analysis included in the report which provides granular analysis of more than 20+ countries covered in the report scope
  • The study includes detailed profiles of major manufacturers to help our readers gain holistic overview of the market competitors and consequently align their business strategies

 


 
Chapter 1. Executive Summary
1.1. Market Outlook
1.2. Market Segment Outlook
1.3. Geography Outlook
1.4. Absolute $ Opportunity
 
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Scope, Definition, and Assumptions
2.3. Data Sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary Data Mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
 
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key Trends
3.2.1. End User Trends
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Impact Analysis of Market Drivers
3.3.2. Market Restraints
3.3.2.1. Impact Analysis of Market Restraints
3.3.3. Market Opportunities
3.3.3.1. Impact Analysis of Market Opportunities
3.3.4. Market Challenges
3.3.4.1. Impact Analysis of Market Challenges
3.4. Porter’s Five Forces’ Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of New Entrant
3.4.4. Threat of Substitutes
3.4.5. Competitive Rivalry
3.5. Value Chain Analysis: Global Medical Sterilization Biological Indicator Market
3.6. COVID-19 Impact Assessment in Medical Sterilization Biological Indicator Market
3.6.1. Impact Assessment on Global Medical Sterilization Biological Indicator Market
3.6.2. Market Trends and Opportunities in the Covid-19 Landscape
 
Chapter 4. Global Medical Sterilization Biological Indicator Market Overview, By End User, 2017 - 2028 (USD Million)
4.1. Global Medical Sterilization Biological Indicator Market Share, By End User, 2017 - 2028 (USD Million)
4.1.1. Hospitals
4.1.2. Diagnostic Centers
4.1.3. Pharma Companies
4.1.4. Others
 
Chapter 5. Global Medical Sterilization Biological Indicator Market Overview, By Geography, 2017 - 2028 (USD Million)
5.1. Global Medical Sterilization Biological Indicator Market Share, By Geography, 2017 - 2028 (USD Million)
5.1.1. Market Deployment and Projections, by Countries, 2017 - 2028 (USD Million)
5.1.2. Market Share and CAGR Comparison, by Countries, 2021 (%)
 
Chapter 6. North America Medical Sterilization Biological Indicator Market Overview, By Countries, 2017 - 2028 (USD Million)
6.1. North America Medical Sterilization Biological Indicator Market Overview, 2017 - 2028 (USD Million)
6.1.1. Market Deployment and projections, 2017 - 2028 (USD Million)
6.1.2. North America Medical Sterilization Biological Indicator Market Overview, By End User, 2017 - 2028 (USD Million)
6.2. North America Medical Sterilization Biological Indicator Market Overview, By Countries, 2017 - 2028 (USD Million)
6.2.1. U.S. Medical Sterilization Biological Indicator Market Overview, 2017 - 2028 (USD Million)
6.2.1.1. U.S. Medical Sterilization Biological Indicator Market Overview, By End User, 2017 - 2028 (USD Million)
6.2.2. Canada Medical Sterilization Biological Indicator Market Overview, 2017 - 2028 (USD Million)
6.2.2.1. Canada Medical Sterilization Biological Indicator Market Overview, By End User, 2017 - 2028 (USD Million)
6.2.3. Mexico Medical Sterilization Biological Indicator Market Overview, 2017 - 2028 (USD Million)
6.2.3.1. Mexico Medical Sterilization Biological Indicator Market Overview, By End User, 2017 - 2028 (USD Million)
 
Chapter 7. Europe Medical Sterilization Biological Indicator Market Overview, By Countries, 2017 - 2028 (USD Million)
7.1. Europe Medical Sterilization Biological Indicator Market Overview, 2017 - 2028 (USD Million)
7.1.1. Market Deployment and projections, 2017 - 2028 (USD Million)
7.1.2. Europe Medical Sterilization Biological Indicator Market Overview, By End User, 2017 - 2028 (USD Million)
7.2. Europe Medical Sterilization Biological Indicator Market Overview, By Countries, 2017 - 2028 (USD Million)
7.2.1. Germany Medical Sterilization Biological Indicator Market Overview, 2017 - 2028 (USD Million)
7.2.1.1. Germany Medical Sterilization Biological Indicator Market Overview, By End User, 2017 - 2028 (USD Million)
7.2.2. France Medical Sterilization Biological Indicator Market Overview, 2017 - 2028 (USD Million)
7.2.2.1. France Medical Sterilization Biological Indicator Market Overview, By End User, 2017 - 2028 (USD Million)
7.2.3. UK Medical Sterilization Biological Indicator Market Overview, 2017 - 2028 (USD Million)
7.2.3.1. UK Medical Sterilization Biological Indicator Market Overview, By End User, 2017 - 2028 (USD Million)
7.2.4. Italy Medical Sterilization Biological Indicator Market Overview, 2017 - 2028 (USD Million)
7.2.4.1. Italy Medical Sterilization Biological Indicator Market Overview, By End User, 2017 - 2028 (USD Million)
7.2.5. Spain Medical Sterilization Biological Indicator Market Overview, 2017 - 2028 (USD Million)
7.2.5.1. Spain Medical Sterilization Biological Indicator Market Overview, By End User, 2017 - 2028 (USD Million)
7.2.6. NORDIC Medical Sterilization Biological Indicator Market Overview, 2017 - 2028 (USD Million)
7.2.6.1. NORDIC Medical Sterilization Biological Indicator Market Overview, By End User, 2017 - 2028 (USD Million)
7.2.7. Russia and CIS Medical Sterilization Biological Indicator Market Overview, 2017 - 2028 (USD Million)
7.2.7.1. Russia and CIS Medical Sterilization Biological Indicator Market Overview, By End User, 2017 - 2028 (USD Million)
7.2.8. Rest of Europe Medical Sterilization Biological Indicator Market Overview, 2017 - 2028 (USD Million)
7.2.8.1. Rest of Europe Medical Sterilization Biological Indicator Market Overview, By End User, 2017 - 2028 (USD Million)
 
Chapter 8. Asia Pacific Medical Sterilization Biological Indicator Market Overview, By Countries, 2017 - 2028 (USD Million)
8.1. Asia Pacific Medical Sterilization Biological Indicator Market Overview, 2017 - 2028 (USD Million)
8.1.1. Market Deployment and projections, 2017 - 2028 (USD Million)
8.1.2. Asia Pacific Medical Sterilization Biological Indicator Market Overview, By End User, 2017 - 2028 (USD Million)
8.2. Asia Pacific Medical Sterilization Biological Indicator Market Overview, By Countries, 2017 - 2028 (USD Million)
8.2.1. India Medical Sterilization Biological Indicator Market Overview, 2017 - 2028 (USD Million)
8.2.1.1. India Medical Sterilization Biological Indicator Market Overview, By End User, 2017 - 2028 (USD Million)
8.2.2. China Medical Sterilization Biological Indicator Market Overview, 2017 - 2028 (USD Million)
8.2.2.1. China Medical Sterilization Biological Indicator Market Overview, By End User, 2017 - 2028 (USD Million)
8.2.3. Japan Medical Sterilization Biological Indicator Market Overview, 2017 - 2028 (USD Million)
8.2.3.1. Japan Medical Sterilization Biological Indicator Market Overview, By End User, 2017 - 2028 (USD Million)
8.2.4. ASEAN Medical Sterilization Biological Indicator Market Overview, 2017 - 2028 (USD Million)
8.2.4.1. ASEAN Medical Sterilization Biological Indicator Market Overview, By End User, 2017 - 2028 (USD Million)
8.2.5. South Korea Medical Sterilization Biological Indicator Market Overview, 2017 - 2028 (USD Million)
8.2.5.1. South Korea Medical Sterilization Biological Indicator Market Overview, By End User, 2017 - 2028 (USD Million)
8.2.6. Australia Medical Sterilization Biological Indicator Market Overview, 2017 - 2028 (USD Million)
8.2.6.1. Australia Medical Sterilization Biological Indicator Market Overview, By End User, 2017 - 2028 (USD Million)
8.2.7. Rest of Asia Pacific Medical Sterilization Biological Indicator Market Overview, 2017 - 2028 (USD Million)
8.2.7.1. Rest of Asia Pacific Medical Sterilization Biological Indicator Market Overview, By End User, 2017 - 2028 (USD Million)
 
Chapter 9. South America Medical Sterilization Biological Indicator Market Overview, By Countries, 2017 - 2028 (USD Million)
9.1. South America Medical Sterilization Biological Indicator Market Overview, 2017 - 2028 (USD Million)
9.1.1. Market Deployment and projections, 2017 - 2028 (USD Million)
9.1.2. South America Medical Sterilization Biological Indicator Market Overview, By End User, 2017 - 2028 (USD Million)
9.2. South America Medical Sterilization Biological Indicator Market Overview, By Countries, 2017 - 2028 (USD Million)
9.2.1. Brazil Medical Sterilization Biological Indicator Market Overview, 2017 - 2028 (USD Million)
9.2.1.1. Brazil Medical Sterilization Biological Indicator Market Overview, By End User, 2017 - 2028 (USD Million)
9.2.2. Argentina Medical Sterilization Biological Indicator Market Overview, 2017 - 2028 (USD Million)
9.2.2.1. Argentina Medical Sterilization Biological Indicator Market Overview, By End User, 2017 - 2028 (USD Million)
9.2.3. Rest of South America Medical Sterilization Biological Indicator Market Overview, 2017 - 2028 (USD Million)
9.2.3.1. Rest of South America Medical Sterilization Biological Indicator Market Overview, By End User, 2017 - 2028 (USD Million)
 
Chapter 10. Middle East & Africa Medical Sterilization Biological Indicator Market Overview, By Countries, 2017 - 2028 (USD Million)
10.1. Middle East & Africa Medical Sterilization Biological Indicator Market Overview, 2017 - 2028 (USD Million)
10.1.1. Market Deployment and projections, 2017 - 2028 (USD Million)
10.1.2. Middle East & Africa Medical Sterilization Biological Indicator Market Overview, By End User, 2017 - 2028 (USD Million)
10.2. Middle East & Africa Medical Sterilization Biological Indicator Market Overview, By Countries, 2017 - 2028 (USD Million)
10.2.1. GCC Medical Sterilization Biological Indicator Market Overview, 2017 - 2028 (USD Million)
10.2.1.1. GCC Medical Sterilization Biological Indicator Market Overview, By End User, 2017 - 2028 (USD Million)
10.2.2. South Africa Medical Sterilization Biological Indicator Market Overview, 2017 - 2028 (USD Million)
10.2.2.1. South Africa Medical Sterilization Biological Indicator Market Overview, By End User, 2017 - 2028 (USD Million)
10.2.3. Rest of Middle East & Africa Medical Sterilization Biological Indicator Market Overview, 2017 - 2028 (USD Million)
10.2.3.1. Rest of Middle East & Africa Medical Sterilization Biological Indicator Market Overview, By End User, 2017 - 2028 (USD Million)
 
Chapter 11. Competitive Landscape
11.1. Competitive Environment, 2021
11.2. Strategic Framework
11.2.1. Partnership/Collaborations/Agreement
11.2.2. Expansion
11.2.3. Mergers & Acquisitions
11.2.4. New Product Development
 
Chapter 12. Key Vendor Analysis
12.1. 3M Company
12.1.1. Business Overview
12.1.2. Product Benchmarking
12.1.3. Financial Data
12.1.4. Strategic Overview
12.1.5. Key Developments
12.1.6. SWOT Analysis
12.2. Steris Plc.
12.2.1. Business Overview
12.2.2. Product Benchmarking
12.2.3. Financial Data
12.2.4. Strategic Overview
12.2.5. Key Developments
12.2.6. SWOT Analysis
12.3. Getinge AB
12.3.1. Business Overview
12.3.2. Product Benchmarking
12.3.3. Financial Data
12.3.4. Strategic Overview
12.3.5. Key Developments
12.3.6. SWOT Analysis
12.4. Thermo Fisher Scientific Inc.
12.4.1. Business Overview
12.4.2. Product Benchmarking
12.4.3. Financial Data
12.4.4. Strategic Overview
12.4.5. Key Developments
12.4.6. SWOT Analysis
12.5. Mesa Labs, Inc.
12.5.1. Business Overview
12.5.2. Product Benchmarking
12.5.3. Financial Data
12.5.4. Strategic Overview
12.5.5. Key Developments
12.5.6. SWOT Analysis
12.6. McKesson Medical-Surgical Inc.
12.6.1. Business Overview
12.6.2. Product Benchmarking
12.6.3. Financial Data
12.6.4. Strategic Overview
12.6.5. Key Developments
12.6.6. SWOT Analysis
12.7. Crosstex International, Inc. (Cantel Medical Corp.)
12.7.1. Business Overview
12.7.2. Product Benchmarking
12.7.3. Financial Data
12.7.4. Strategic Overview
12.7.5. Key Developments
12.7.6. SWOT Analysis
12.8. Propper Manufacturing Co., Inc.
12.8.1. Business Overview
12.8.2. Product Benchmarking
12.8.3. Financial Data
12.8.4. Strategic Overview
12.8.5. Key Developments
12.8.6. SWOT Analysis
12.9. Liofilchem S.r.l.
12.9.1. Business Overview
12.9.2. Product Benchmarking
12.9.3. Financial Data
12.9.4. Strategic Overview
12.9.5. Key Developments
12.9.6. SWOT Analysis
12.10. Terragene S.A.
12.10.1. Business Overview
12.10.2. Product Benchmarking
12.10.3. Financial Data
12.10.4. Strategic Overview
12.10.5. Key Developments
12.10.6. SWOT Analysis
12.11. GKE-GmbH
12.11.1. Business Overview
12.11.2. Product Benchmarking
12.11.3. Financial Data
12.11.4. Strategic Overview
12.11.5. Key Developments
12.11.6. SWOT Analysis
 
Chapter 13. Future Outlook of the Market

 

Request For Methodology

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

Request For List Of Tables

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

FAQ

Choose License Type

Single User

US$ 3500

Multi User

US$ 5250

Corporate User

US$ 7000

Personalize this Research

  • Market Size and Share from 2016 - 2027
  • Expected Market Growth Until 2027
  • COVID-19 Impact assessment on the market
  • Market Dynamics and Impact Analysis
  • Segment and region that will drive or lead the market growth and why
  • Industry activity comprising Mergers, Acquisitions, Expansion, etc.
  • Comprehensive Mapping of the Competitive Landscape
  • In-depth analysis of key sustainability strategies adopted by market players
  • Global and regional market trends – Current and Future
  • Value Chain Analysis
  • Porters Five Forces Analysis
  • Historical and Current Product Pricing
  • Country Cross-Segment Analysis
  • Company Profiling
  • Player Comparison Matrix

Life Science Clients

Medical Sterilization Biological Indicator Market ...

RD Code : HP22